Lucia Moreira-Teixeira

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Authors (341)

Catherine F Houlihan
Nina Vora
Thomas Byrne
Dan Lewer
Gavin Kelly
Judith Heaney
[...]
Andrew Hayward
Richard Gilson
Gavin Kelly
Fiona Roberts
Emine Hatipoglu

Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis

Authors (19)

Lucia Moreira-Teixeira
Olivier Tabone
Christine Graham
Akul Singhania
Evangelos Stavropoulos
Paul S Redford
[...]
Baltazar Cá
Raman Verma
Pranabashis Haldar
Margarida Saraiva
Anne O'Garra

Nature Immunology

Published 1 April 2020

Crick labs/ facilities

Full details

Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases

Authors (35)

Nature Communications

Published 28 June 2019

Crick labs/ facilities

Full details

Type I interferons in tuberculosis: Foe and occasionally friend

Authors (4)

Lucia Moreira-Teixeira
Katrin Mayer-Barber
Alan Sher
Anne O'Garra

Journal of Experimental Medicine

Published 7 May 2018

Crick labs

Anne O’Garra

Full details

T cell-derived IL-10 impairs host resistance to Mycobacterium tuberculosis infection

Authors (10)

Lucia Moreira-Teixeira
Paul S Redford
Evangelos Stavropoulos
Nico Ghilardi
Craig L Maynard
Casey T Weaver
Ana Paula Freitas do Rosário
Xuemei Wu
Jean Langhorne
Anne O'Garra

Journal of Immunology

Published 5 June 2017

Crick labs

Full details

Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling

Authors (14)

Lucia Moreira-Teixeira
Jeremy Sousa
Finlay W McNab
Egídio Torrado
Filipa Cardoso
Henrique Machado
[...]
Xuemei Wu
Rui Appelberg
António Gil Castro
Anne O'Garra
Margarida Saraiva

Journal of Immunology

Published 14 November 2016

Crick labs/ facilities

Full details

Analysis of transcriptional signatures in response to Listeria monocytogenes infection reveals temporal changes that result from type I interferon signaling

Authors (12)

Jonathan M Pitt
Simon Blankley
Krzysztof Potempa
Christine Graham
Lucia Moreira-Teixeira
Finlay W McNab
[...]
Evangelos Stavropoulos
Virginia Pascual
Jacques Banchereau
Damien Chaussabel
Anne O'Garra

PLOS ONE

Published 1 January 2016

Crick labs/ facilities

Full details

Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages

Authors (8)

Finlay W McNab
John Ewbank
Ashleigh Howes
Lucia Moreira-Teixeira
Anna Martirosyan
Nico Ghilardi
Margarida Saraiva
Anne O'Garra

Journal of Immunology

Published 3 September 2014

Crick labs

Anne O’Garra

Full details

A-Z of research labs

Engaging our community

Staff and visitors to the Crick during the coronavirus outbreak

Coronavirus (COVID-19) research

Francis Crick Institute coronavirus (COVID-19) response

Lucia Moreira-Teixeira

Year published

Research topics

Crick Pre-Crick

Publication type

Journal

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis

Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases

Type I interferons in tuberculosis: Foe and occasionally friend

T cell-derived IL-10 impairs host resistance to Mycobacterium tuberculosis infection

Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling

Analysis of transcriptional signatures in response to Listeria monocytogenes infection reveals temporal changes that result from type I interferon signaling

Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages

The Francis Crick Institute is a unique partnership between